2,4-DIAMINOPYRIMIDINE DERIVATES AS PTK2- INHIBITORS FOR THE TREATMENT OF ABNORMAL CELL GROWTH
申请人:Sapountzis Ioannis
公开号:US20110275633A1
公开(公告)日:2011-11-10
The present invention encompasses compounds of general formula (1) wherein R
1
-R
3
and n are defined as in claim
1,
which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.
本发明涵盖了通式(1)中R1-R3和n的定义如权利要求1所述的化合物,适用于治疗由过度或异常细胞增殖所特征的疾病,并且它们用于制备具有上述特性的药物。